Fig 1: NER contributes significantly to GC/GC outcomes and to successful replication. (A) Lesion‐specific qPCR and NGS give identical results. NGS data from two repeats of control and PIR peptide‐treated CPD replication reactions in TK6 extracts are compared with qPCR measurements (mean and SD of four experiments) of the same experimental conditions. Only correct TLS and GC/GC outcomes are shown. (B) Bypass outcomes upon PIR and RIR peptide interference in NER‐proficient and NER‐deficient TK6 extract. Mean and SD of 3–4 experiments are shown. (C) Decreasing replication efficiency with increasing PIR concentration. (D) TT(CPD) bypass in NER‐deficient TK6 extract under interference by two PCNA variants or the UBZ protein domain. Mean and SD of three experiments are shown. (E) An increase in postreplicative gaps (deletions at the lesion, GAP) in the same experiments as in panel (D) indicates less efficient complete replication in NER‐deficient extracts. (F) TLS on TT(6‐4) containing pUCQF plasmid is as inefficient in TK6 (WT or XPA mutant) extracts as in HeLa extract. No significant effects were seen in replication outcomes with the indicated interference approaches. For all panels, peptides and proteins were added at concentrations specified in the Materials and methods unless otherwise indicated.
Fig 2: NER can remove both TT(CPD) and TT(6‐4) photolesions during incubation in cellular extract. (A) Control melting curves of PCR products generated from template DNAs with different individual lesion‐bypass sequences (GC/GAP, GC/GC, GC/TT, TT/GC, GAP/GC) at the lesion sites. (B, C) Melt curves of 140 bp PCR products generated by nested PCR on TT(CPD) templates (B) and TT(6‐4) templates (C) recovered from replication reactions in the absence or presence of T antigen. A complex curve was observed in the presence of T antigen (yellow) with TT(CPD) material giving rise to many TLS events, whereas a simple curve (red) similar to that obtained with the lesionless material (black) was generated with the NER‐proficient extract on both lesions. Curves obtained with templates from the NER‐deficient XPA −/− extract (blue) are different from those obtained with lesionless constructs, suggesting a failure of lesion removal. Recombinantly expressed and purified XPA complemented the XPA −/− extract (dark blue line). (D) SDS/PAGE image of the purified recombinant XPA protein preparation used in (C). The experiments were performed several times; representative melting curves are shown in panels (A, B, D). (E) Sequencing chromatogram of the lesionless control plasmid, with the sites of the lesions marked with asterisks. (F, G) Short sections of sequencing chromatograms of bulk lesion‐containing plasmid DNA prepared after incubation in TK6 NER‐proficient (WT) or NER‐deficient (XPA −/−) extracts in the absence or presence of T antigen as shown. The lesion sites are marked with red bars below the sequence (B, bottom strand; T, top strand). Double peaks indicating shorter and longer PCR products are seen on the sequencing chromatograms in NER‐deficient conditions at the top lesion site in case of both CPD and 6‐4 photoproducts. Almost perfect sequences with GC (blue asterisk) at the lesion sites are seen in the NER‐proficient extracts. Signs of TLS (marked with red and green asterisks) are observed with TT(CPD) lesion in XPA extracts.
Supplier Page from OriGene Technologies for XPA (NM_000380) Human Untagged Clone